Literature DB >> 2881620

Verapamil reversal of vincristine resistance and cross-resistance patterns of vincristine-resistant Chinese hamster ovary cells.

F Brewer, J R Warr.   

Abstract

The phenotypic properties of a large number of low-level vincristine (VCR)-resistant Chinese hamster ovary cell lines have been studied. In particular, we examined the correlation between the reversal of VCR resistance by verapamil (VRP) and cross-resistance patterns to other drugs. Cross resistance to other vinca alkaloids developed in parallel with VCR resistance. Doxorubicin resistance was observed in many of the cell lines, occurring even at the lowest levels of VCR resistance. Increased sensitivity to taxol (TAX) was a feature of half of the lines tested and there was no increased resistance to 5-fluorouracil or chlorambucil. Two main groups of mutants have been identified: (a) those that are thought to be membrane mutants which are cross-resistant to TAX and whose VCR resistance is reversible by VRP; and (b) those that appear to be tubulin mutants, which have increased sensitivity to TAX and resistance to VCR in the presence of VRP. It was not possible to distinguish between the different mechanisms of low-level resistance by drug accumulation studies in unsupplemented medium. However, VCR accumulation in the presence of VRP did correlate with the cross-resistance results.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2881620

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  5 in total

Review 1.  Clinical pharmacokinetics of vinorelbine.

Authors:  D Levêque; F Jehl
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

Review 2.  Is resistance useless? Multidrug resistance and collateral sensitivity.

Authors:  Matthew D Hall; Misty D Handley; Michael M Gottesman
Journal:  Trends Pharmacol Sci       Date:  2009-09-15       Impact factor: 14.819

Review 3.  Studies on low-level MDR cells.

Authors:  G Belvedere; E Dolfini
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

4.  Cross-resistance of drug-resistant murine P388 leukemias to taxol in vivo.

Authors:  W R Waud; K S Gilbert; S D Harrison; D P Griswold
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

5.  Suppression of anti-microtubule agent-induced apoptosis by nitric oxide: possible mechanism of a new drug resistance.

Authors:  T Ogura; G DeGeorge; M Tatemichi; H Esumi
Journal:  Jpn J Cancer Res       Date:  1998-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.